Nimodipine Administration for Aneurysmal Subarachnoid Hemorrhage

Critical Dosing and Administration

The American Heart Association recommends nimodipine must be dosed every 4 hours (6 times daily), not QID (4 times daily), to avoid common and dangerous prescribing errors 1, 2, 3

The American College of Cardiology suggests managing hypotension with standard medical interventions (vasopressors, fluids) rather than stopping nimodipine, and maintaining euvolemia with crystalloid infusions to support blood pressure 1, 2
Temporary stoppage of nimodipine may be necessary only if it causes significant blood pressure variability that cannot be managed with vasopressors 1, 2
Maintaining full dosing of nimodipine is associated with reduced delayed cerebral ischemia (inverse correlation ρ=-0.273, p<0.001) and better functional outcomes 1, 2

The American Heart Association recommends monitoring for delayed cerebral ischemia (DCI) throughout the 21-day treatment period 1, 2, 3
A meta-analysis of 16 trials (3,361 patients) confirms nimodipine prevents DCI and improves functional outcomes 1, 2
Disruption of nimodipine is associated with greater DCI incidence (ρ=0.431, p<0.001) 1, 2

The American College of Cardiology advises against using sublingual nifedipine as a substitute for nimodipine, as it causes precipitous blood pressure drops and is not recommended 4